Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis

ISSN： 0340-5761

Source： Archives of Toxicology, Vol.82, Iss.12, 2008-12, pp. : 959-964

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A New Approach to Drug Therapy in Non-alcoholic Steatohepatitis (NASH)

By Fehér J Lengyel G

The Journal of International Medical Research, Vol. 31, Iss. 6, 2003-11 ,pp. : 537-551

Field House Publishing

Access to resources Recommend Favorite

Emerging drugs for non-alcoholic steatohepatitis

By Tomeno Wataru Yoneda Masato Imajo Kento Ogawa Yuji Kessoku Takaomi Saito Satoru Eguchi Yuichiro Nakajima Atsushi

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 3, 2013-09 ,pp. : 279-290

Informa Healthcare

Access to resources Recommend Favorite

Evolving therapies for non-alcoholic steatohepatitis

By Tilg Herbert Moschen Alexander R

Expert Opinion on Drug Discovery, Vol. 9, Iss. 6, 2014-06 ,pp. : 687-696

Informa Healthcare

Access to resources Recommend Favorite

Prediction of Human Drug Metabolizing Enzyme Induction

Current Drug Metabolism, Vol. 4, Iss. 5, 2003-10 ,pp. : 381-391

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclophosphamide/dexamethasone: Non-alcoholic steatohepatitis: case report

Reactions Weekly, Vol. 1, Iss. 1233, 2009-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite